SNS01-T

· Senesco Technologies, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SNS01-T, covering 2014-09-11 to 2014-09-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) [Phase 1, Phase 2]

See pricing